AEON Biopharma Management
Management criteria checks 2/4
AEON Biopharma's CEO is Marc Forth, appointed in Dec 2019, has a tenure of 4.92 years. total yearly compensation is $3.98M, comprised of 13.8% salary and 86.2% bonuses, including company stock and options. directly owns 0.18% of the company’s shares, worth $37.09K. The average tenure of the management team and the board of directors is 3.3 years and 1.4 years respectively.
Key information
Marc Forth
Chief executive officer
US$4.0m
Total compensation
| CEO salary percentage | 13.8% |
| CEO tenure | 4.9yrs |
| CEO ownership | 0.2% |
| Management average tenure | 3.3yrs |
| Board average tenure | 1.4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$306m |
| Mar 31 2024 | n/a | n/a | -US$137m |
| Dec 31 2023 | US$4m | US$550k | -US$385m |
| Sep 30 2023 | n/a | n/a | -US$45m |
| Jun 30 2023 | n/a | n/a | -US$78m |
| Mar 31 2023 | n/a | n/a | -US$66m |
| Dec 31 2022 | US$5m | US$550k | -US$53m |
| Sep 30 2022 | n/a | n/a | -US$25m |
| Jun 30 2022 | n/a | n/a | -US$27m |
| Mar 31 2022 | n/a | n/a | -US$61m |
| Dec 31 2021 | n/a | n/a | -US$56m |
| Sep 30 2021 | n/a | n/a | -US$58m |
| Jun 30 2021 | n/a | n/a | -US$54m |
| Mar 31 2021 | n/a | n/a | -US$17m |
| Dec 31 2020 | US$3m | US$524k | -US$50m |
Compensation vs Market: Marc's total compensation ($USD3.98M) is above average for companies of similar size in the US market ($USD650.80K).
Compensation vs Earnings: Marc's compensation has been consistent with company performance over the past year.
CEO
Marc Forth (53 yo)
4.9yrs
Tenure
US$3,982,378
Compensation
Mr. Marc Forth serves as Chief Executive Officer at AEON Biopharma, Inc., since December 2019 and also serves as its Principal Financial Officer since May 17, 2024 and serves as its President. Prior to AEO...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Principal Financial Officer | 4.9yrs | US$3.98m | 0.18% $ 37.1k | |
| Executive VP | 3.3yrs | US$1.40m | 0.052% $ 10.8k | |
| Chief Medical Officer | 3.4yrs | US$1.65m | 0.064% $ 13.3k | |
| Principal Accounting Officer | less than a year | no data | 0% $ 0 |
3.3yrs
Average Tenure
46yo
Average Age
Experienced Management: AEON's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Principal Financial Officer | 1.4yrs | US$3.98m | 0.18% $ 37.1k | |
| Independent Director | 1.4yrs | US$197.87k | 5.73% $ 1.2m | |
| Independent Director | 1.4yrs | US$198.86k | 0% $ 0 | |
| Chairman | 7.8yrs | US$862.46k | 0.11% $ 23.2k | |
| Independent Director | 1.4yrs | US$216.91k | 0% $ 0 | |
| Director | less than a year | no data | no data |
1.4yrs
Average Tenure
70yo
Average Age
Experienced Board: AEON's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.